
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11.2M | $12.5M | $12.2M | $6.4M | $7.5M | |
Revenue Growth (YoY) | 0.81% | 11.8% | -3.07% | -47% | 16.5% | |
Cost of Revenues | $9.6M | $11.2M | $10M | $5.8M | $6.2M | |
Gross Profit | $1.6M | $1.3M | $2.2M | $633.3K | $1.3M | |
Gross Profit Margin | 14.07% | 10.46% | 18.06% | 9.83% | 17.47% | |
R&D Expenses | -- | -- | -- | -- | $649.8K | |
Selling, General & Admin | $2.6M | $3.1M | $4.3M | $4.5M | $4.5M | |
Other Inc / (Exp) | $21.8K | $411K | $581.3K | $203.6K | $180.1K | |
Operating Expenses | $2.6M | $3.1M | $4.3M | $4.5M | $5.2M | |
Operating Income | -$1M | -$1.7M | -$2.1M | -$3.9M | -$3.8M | |
Net Interest Expenses | $28.9K | $57.6K | $119.7K | -- | -- | |
EBT. Incl. Unusual Items | -$1M | -$1.4M | -$1.7M | -$3.4M | -$3.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $56.2K | $83.2K | |
Net Income to Company | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Basic EPS (Cont. Ops) | -$0.06 | -$0.08 | -$0.11 | -$0.19 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.06 | -$0.08 | -$0.11 | -$0.19 | -$0.20 | |
Weighted Average Basic Share | $18.1M | $18.1M | $15.3M | $18.1M | $18.1M | |
Weighted Average Diluted Share | $18.1M | $18.1M | $15.3M | $18.1M | $18.1M | |
EBITDA | -$720.6K | -$1.1M | -$1.2M | -$2.7M | -$2.8M | |
EBIT | -$986.2K | -$1.3M | -$1.5M | -$3.4M | -$3.6M | |
Revenue (Reported) | $11.2M | $12.5M | $12.2M | $6.4M | $7.5M | |
Operating Income (Reported) | -$1M | -$1.7M | -$2.1M | -$3.9M | -$3.8M | |
Operating Income (Adjusted) | -$986.2K | -$1.3M | -$1.5M | -$3.4M | -$3.6M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11.2M | $12.5M | $12.2M | $6.4M | $7.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.6M | $11.2M | $10M | $5.8M | $6.2M | |
Gross Profit | $1.6M | $1.3M | $2.2M | $633.3K | $1.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $649.8K | |
Selling, General & Admin | $2.6M | $3.1M | $4.3M | $4.5M | $4.5M | |
Other Inc / (Exp) | $21.8K | $410.9K | $581.3K | $203.6K | $180.1K | |
Operating Expenses | $2.6M | $3.1M | $4.3M | $4.5M | $5.2M | |
Operating Income | -$1M | -$1.7M | -$2.1M | -$3.9M | -$3.8M | |
Net Interest Expenses | $28.9K | $57.6K | $119.7K | -- | -- | |
EBT. Incl. Unusual Items | -$1M | -$1.4M | -$1.7M | -$3.4M | -$3.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $56.2K | $83.2K | |
Net Income to Company | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Basic EPS (Cont. Ops) | -$0.06 | -$0.08 | -$0.09 | -$0.19 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.06 | -$0.08 | -$0.09 | -$0.19 | -$0.20 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$720.6K | -$1.1M | -$1.2M | -$2.7M | -$2.8M | |
EBIT | -$986.2K | -$1.3M | -$1.5M | -$3.4M | -$3.6M | |
Revenue (Reported) | $11.2M | $12.5M | $12.2M | $6.4M | $7.5M | |
Operating Income (Reported) | -$1M | -$1.7M | -$2.1M | -$3.9M | -$3.8M | |
Operating Income (Adjusted) | -$986.2K | -$1.3M | -$1.5M | -$3.4M | -$3.6M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $302.4K | $131.1K | $9.2M | $4.5M | $1.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $789.9K | $1.1M | $1.6M | $445.5K | $139.2K | |
Inventory | $4.4M | $5.1M | $4.5M | $5M | $5M | |
Prepaid Expenses | $166.6K | $306.7K | $487.7K | $1.9M | $2.2M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.1M | $7.1M | $16M | $12.1M | $8.8M | |
Property Plant And Equipment | $2.4M | $2.2M | $5.8M | $6.1M | $5.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $8.5M | $9.3M | $21.8M | $18.3M | $14.4M | |
Accounts Payable | $1.3M | $1.9M | $396.6K | $324.6K | $251.1K | |
Accrued Expenses | $901.4K | $1.5M | $497.5K | $465.3K | $370.5K | |
Current Portion Of Long-Term Debt | $720.5K | $762.8K | $201.2K | $129.7K | $170.7K | |
Current Portion Of Capital Lease Obligations | $386.4K | $447.3K | $531.8K | $279.3K | $493.1K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.5M | $4.9M | $1.8M | $1.4M | $1.4M | |
Long-Term Debt | $349.4K | $498.4K | $417.8K | $334.3K | $248.8K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.4M | $5.8M | $2.4M | $1.9M | $1.8M | |
Common Stock | $1.3K | $1.3K | $1.8K | $1.8K | $1.8K | |
Other Common Equity Adj | $323K | $375.3K | -$45.6K | -$260.6K | -$334.6K | |
Common Equity | $4.1M | $3.5M | $19.5M | $16.4M | $12.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.1M | $3.5M | $19.5M | $16.4M | $12.6M | |
Total Liabilities and Equity | $8.5M | $9.3M | $21.8M | $18.3M | $14.4M | |
Cash and Short Terms | $302.4K | $131.1K | $9.2M | $4.5M | $1.3M | |
Total Debt | $1.1M | $1.3M | $619K | $464K | $419.5K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $302.4K | $131.1K | $9.2M | $4.5M | $1.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $789.9K | $1.1M | $1.6M | $445.5K | $139.2K | |
Inventory | $4.4M | $5.1M | $4.5M | $5M | $5M | |
Prepaid Expenses | $166.6K | $306.7K | $487.7K | $1.9M | $2.2M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.1M | $7.1M | $16M | $12.1M | $8.8M | |
Property Plant And Equipment | $2.4M | $2.2M | $5.8M | $6.1M | $5.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $8.5M | $9.3M | $21.8M | $18.3M | $14.4M | |
Accounts Payable | $1.3M | $1.9M | $396.6K | $324.6K | $251.1K | |
Accrued Expenses | $901.4K | $1.5M | $497.5K | $465.3K | $370.5K | |
Current Portion Of Long-Term Debt | $720.5K | $762.8K | $201.2K | $129.7K | $170.7K | |
Current Portion Of Capital Lease Obligations | $386.4K | $447.3K | $531.8K | $279.3K | $493.1K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.5M | $4.9M | $1.8M | $1.4M | $1.4M | |
Long-Term Debt | $349.4K | $498.4K | $417.8K | $334.3K | $248.8K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.4M | $5.8M | $2.4M | $1.9M | $1.8M | |
Common Stock | $1.3K | $1.3K | $1.8K | $1.8K | $1.8K | |
Other Common Equity Adj | $323K | $375.3K | -$45.6K | -$260.6K | -$334.6K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.1M | $3.5M | $19.5M | $16.4M | $12.6M | |
Total Liabilities and Equity | $8.5M | $9.3M | $21.8M | $18.3M | $14.4M | |
Cash and Short Terms | $302.4K | $131.1K | $9.2M | $4.5M | $1.3M | |
Total Debt | $1.1M | $1.3M | $619K | $464K | $419.5K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Depreciation & Amoritzation | $265.7K | $259.1K | $303.3K | $693.5K | $797.7K | |
Stock-Based Compensation | -- | -- | -- | $667K | -- | |
Change in Accounts Receivable | -$154.9K | -$333.6K | -$429.3K | $1.1M | $385.6K | |
Change in Inventories | -$683.7K | -$712.9K | $535.2K | -$586.6K | -$7.7K | |
Cash From Operations | -$1.6M | -$1M | -$4.2M | -$3.2M | -$3M | |
Capital Expenditures | $221.8K | $9.8K | $4.2M | $1.4M | $115.2K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$221.8K | -$9.8K | -$4.2M | -$1.4M | -$115.2K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $927.5K | $191.3K | $2M | -- | $36.8K | |
Long-Term Debt Repaid | -$32K | -$33K | -$2.6M | -$155K | -$81.4K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $153.9K | $718K | -- | -- | -- | |
Cash From Financing | $1M | $876.3K | $17.4M | -$155K | -$44.6K | |
Beginning Cash (CF) | $1.1M | $302.4K | $131.1K | $9.2M | $4.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$771.4K | -$172.4K | $9M | -$4.7M | -$3.2M | |
Ending Cash (CF) | $302.4K | $131.1K | $9.2M | $4.5M | $1.3M | |
Levered Free Cash Flow | -$1.8M | -$1M | -$8.4M | -$4.5M | -$3.2M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1M | -$1.4M | -$1.7M | -$3.5M | -$3.7M | |
Depreciation & Amoritzation | $265.7K | $259.1K | $303.3K | $693.5K | $797.7K | |
Stock-Based Compensation | -- | -- | -- | $667K | -- | |
Change in Accounts Receivable | -$154.9K | -$333.6K | -$429.3K | $1.1M | $385.6K | |
Change in Inventories | -$683.7K | -$712.9K | $535.2K | -$586.6K | -$7.6K | |
Cash From Operations | -$1.6M | -$1M | -$4.2M | -$3.2M | -$3M | |
Capital Expenditures | $221.8K | $9.8K | $4.2M | $1.4M | $115.2K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$221.8K | -$9.8K | -$4.2M | -$1.4M | -$115.2K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $927.5K | $191.3K | $2M | -- | -- | |
Long-Term Debt Repaid | -$32K | -$33K | -$2.6M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $153.8K | $717.9K | -- | -- | -- | |
Cash From Financing | $1M | $876.3K | $17.4M | -$155K | -$44.6K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$766.9K | -$171.9K | $9M | -$4.7M | -$3.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$1.8M | -$1M | -$8.4M | -$4.5M | -$3.2M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.